Alembic Pharmaceuticals Ltd
Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:	533573	NSE Symbol:	APLLTD	P/E :	21.35
ISIN Demat:	INE901L01018	Div & Yield %:	1.59	EPS :	35.39
Book Value:	285.67	Market Cap (Rs. Cr.):	14,849.36	Face Value :	2

Date	Headline
22-May-26	Alembic Pharmaceuticals receives USFDA approval for Levothyroxine Sodium Tablets
15-May-26	Board of Alembic Pharmaceuticals recommends final dividend
14-May-26	Alembic Pharmaceuticals receives USFDA approval for Darolutamide Tablets, 300 mg
28-Apr-26	Alembic Pharmaceuticals to discuss results & dividend
25-Apr-26	Alembic Pharmaceuticals receives USFDA approval for Fingolimod Capsules
16-Apr-26	Alembic Pharmaceuticals receives USFDA approval for Methotrexate Injection
07-Apr-26	Alembic Pharmaceuticals receives USFDA approval for Dapagliflozin Tablets, 5 mg and 10 mg
06-Mar-26	Alembic Pharmaceuticals announces first prescription-based sale of Pivya® (pivmecillinam) tablets
26-Feb-26	Alembic Pharmaceuticals receives USFDA approval for Lamotrigine Orally Disintegrating Tablets
24-Feb-26	Alembic Pharma receives USFDA approval for Efinaconazole Topical Solution, 10%

Company Snapshot